Wednesday, 05 August 2020


Siemens Competition for science talent on

01 November 2012 | News | By BioSpectrum Bureau

17-year-old designs drug to kill cancer, wins $100,000

Ms Angela Zhang: Developed a potential cure for cancer at 17. What else will she develop in the future?

Ms Angela Zhang: Developed a potential cure for cancer at 17. What else will she develop in the future?

Singapore: Siemens Foundation has announced the semi-finalists and regional finalists of the Siemens Competition in Math, Science & Technology for high school students in the US. The competition is one of the most coveted teen science prizes in the country. The finalists will now compete for the grand prize from December 1 to 4, 2012, in Washington, DC.

In 2011, Ms Angela Zhang won the $100,000 first prize for designing a nanoparticle that showed potential to kill cancer. The 17-year-old's project was titled 'Design of image-guided, photo-thermal controlled drug releasing multifunctional nanosystem for the treatment of cancer stem cells'.

Ms Zhang was born to Chinese immigrants and lives in Cupertino, California, in the US, and a student of Monta Vista High School. Her research earned the nickname 'swiss army knife' in the area of cancer treatment.

The nanoparticle is delivered to tumors via the drug salinomycin where it kills cancer cells and deposits gold and iron-oxide materials to help with MRI imaging. Ms Zhang was working on the particle since 2009 (when she must have been 15) and spent about 1,000 hours developing the same.


Sign up for the editor pick and get articles like this delivered right to your inbox.

Editors Pick
+Country Code-Phone Number(xxx-xxxxxxx)


Comments

× Your session has been expired. Please click here to Sign-in or Sign-up
   New User? Create Account




Podcast

 

Survey Box

Should we be cautious of viewing COVID-19 vaccine as silver bullet?

× Please select an option to participate in the poll.
Processing...   View poll results   More polls

× You have successfully cast your vote.
{{ optionDetail.option }}{{ optionDetail.percentage }}%
{{ optionDetail.percentage }}% Complete
More polls